Literature DB >> 16418776

Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease.

Silvia Colucci1, Giulia Taraboletti, Luca Primo, Andrea Viale, Cristina Roca, Donatella Valdembri, Massimo Geuna, Marco Pagano, Maria Grano, Anthony M Pogrel, Adrian L Harris, Nicholas N Athanasou, Alberto Mantovani, Alberta Zallone, Federico Bussolino.   

Abstract

UNLABELLED: We studied the biological features and the immunophenotype of a cell culture established from the lesion of soft tissues of a woman affected by Gorham-Stout syndrome. We found that these cells belonged to a monocytic lineage with some characteristics of immature osteoclasts and were able to release large amounts of osteoclastogenic and angiogenic molecules that may contribute to disease progression.
INTRODUCTION: Gorham-Stout syndrome is a rare disease characterized by osteolysis and proliferation of vascular or lymphatic vessels, with a severe outcome. Its etiology and the identification of the cell types involved are completely unknown.
MATERIALS AND METHODS: A cell culture from a lesion of soft tissues was established, and its behavior in vitro and in immunodeficient mice was studied. We analyzed (1) the cell phenotype by flow cytometry; (2) the adhesive and migratory properties on different substrates; (3) the ability to differentiate into mature osteoclasts; (4) the production of osteclastogenic and angiogenic molecules; (5) the in vivo angiogenic activity of the cells subcutaneously implanted in mouse in a Matrigel plug; and (6) the ability to recapitulate the disease when transplanted in nude mice. RESULTS AND
CONCLUSIONS: The established culture consisted of a morphologically homogeneous cell population belonging to a monocytic lineage having some features of an osteoclast-like cell type. Cells had an invasive phenotype, were angiogenic, and produced osteoclastogenic (IL-6, TGF-beta1, IL-1beta) and angiogenic (vascular endothelial growth factor-A [VEGF-A], CXCL-8) molecules when challenged with inflammatory cytokines. Immunodeficient mice injected with these cells did not show any bone lesions or vascular alteration, but had high amounts of circulating human IL-6 and VEGF-A. Cells isolated from a cutaneous lymphangiomatosis did not show any of these findings. These data suggest that cells of monocyte-macrophage lineage play an essential role in the pathogenesis of Gorham-Stout disease, whose progression is propelled by cytokine circuits that accelerate angiogenesis and osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16418776     DOI: 10.1359/JBMR.051019

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

1.  Case Report: Gorham-Stoute Syndrome with Involvement of Majority of Mandible, and Partial Maxillary, Temporal and Zygomatic Bones.

Authors:  Mustafa Kürşat Evrenos; Merve Özkaya; Murat Yaman; Levent Yoleri Proff
Journal:  J Maxillofac Oral Surg       Date:  2015-12-08

Review 2.  Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion.

Authors:  Maria José Franco-Barrera; Maria Guadalupe Zavala-Cerna; Georgina Aguilar-Portillo; Diana Brisa Sánchez-Gomez; Olivia Torres-Bugarin; Miguel Angel Franco-Barrera; Carlos Manuel Roa-Encarnacion
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 3.  Vanishing bone disease (Gorham-Stout syndrome): A review of a rare entity.

Authors:  Vasileios S Nikolaou; Dimitrios Chytas; Demitrios Korres; Nicolas Efstathopoulos
Journal:  World J Orthop       Date:  2014-11-18

4.  Lymphatic Endothelial Cells Produce M-CSF, Causing Massive Bone Loss in Mice.

Authors:  Wensheng Wang; Hua Wang; Xichao Zhou; Xing Li; Wen Sun; Michael Dellinger; Brendan F Boyce; Lianping Xing
Journal:  J Bone Miner Res       Date:  2017-01-31       Impact factor: 6.741

Review 5.  Novel molecular pathways in Gorham disease: implications for treatment.

Authors:  Jeroen Hagendoorn; Torunn I Yock; Inne H M Borel Rinkes; Timothy P Padera; David H Ebb
Journal:  Pediatr Blood Cancer       Date:  2013-11-08       Impact factor: 3.167

6.  Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.

Authors:  Sébastien Héritier; Martine Le Merrer; Francis Jaubert; Michèle Bigorre; Marion Gillibert-Yvert; Benoit de Courtivron; Makram Ziade; Yves Bertrand; Christian Carrie; Pascal Chastagner; Cécile Bost-Bru; Jean-Claude Léonard; Marie Ouache; Liliane Boccon-Gibod; Pierre Mary; Jacques de Blic; Isabelle Pin; Daniel Wendling; Yann Revillon; Véronique Houdoin; Véronique Forin; Hubert Ducou Lepointe; Jane Languepin; Jeanne Wagnon; Ralph Epaud; Brigitte Fauroux; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2010-02-03       Impact factor: 4.123

7.  Vascular lesions of bone in children, adolescents, and young adults. A clinicopathologic reappraisal and application of the ISSVA classification.

Authors:  Elisabeth Bruder; Antonio R Perez-Atayde; Gernot Jundt; Ahmad I Alomari; Johannes Rischewski; Steven J Fishman; John B Mulliken; Harry P W Kozakewich
Journal:  Virchows Arch       Date:  2008-12-24       Impact factor: 4.064

8.  Hemangioma of the mandible: case report with special emphasis on bone degradation.

Authors:  Torsten Hansen; Martin Kunkel; Detlef Katenkamp; Sami Eletr; Wilfried Wagner
Journal:  Oral Maxillofac Surg       Date:  2009-12

9.  Gorham-Stout disease: radiological, histological, and clinical features of 12 cases and review of literature.

Authors:  Yi Liu; Ding-Rong Zhong; Pei-Ran Zhou; Fang Lv; Dou-Dou Ma; Wei-Bo Xia; Yan Jiang; Ou Wang; Xiao-Ping Xing; Mei Li
Journal:  Clin Rheumatol       Date:  2014-09-18       Impact factor: 2.980

Review 10.  Gorham-Stout disease of the mandible: case report and review of literature of a rare type of osteolysis.

Authors:  Rohan Jagtap; Swati Gupta; Abdullah Lamfon; Axel Ruprecht; Benjamin Schlott; John Hardeman; Deeba Kashtwari
Journal:  Oral Radiol       Date:  2019-11-18       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.